These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 7986719

  • 41. Recombinant Factor IX Fc Fusion Protein Maintains Full Procoagulant Properties and Exhibits Prolonged Efficacy in Hemophilia B Mice.
    Toby GG, Liu T, Buyue Y, Zhang X, Bitonti AJ, Pierce GF, Sommer JM, Jiang H, Peters RT.
    PLoS One; 2016; 11(2):e0148255. PubMed ID: 26840952
    [Abstract] [Full Text] [Related]

  • 42. The need for highly purified products to treat hemophilia B.
    Scharrer I.
    Acta Haematol; 1995; 94 Suppl 1():2-7. PubMed ID: 7571991
    [Abstract] [Full Text] [Related]

  • 43. A novel rat model of thrombogenicity: its use in evaluation of prothrombin complex concentrates and high purity factor IX concentrates.
    McLaughlin LF, Drummond O, MacGregor IR.
    Thromb Haemost; 1992 Nov 10; 68(5):511-5. PubMed ID: 1455396
    [Abstract] [Full Text] [Related]

  • 44. Large-scale production and properties of a solvent-detergent-treated factor IX concentrate from human plasma.
    Michalski C, Bal F, Burnouf T, Goudemand M.
    Vox Sang; 1988 Nov 10; 55(4):202-10. PubMed ID: 3265237
    [Abstract] [Full Text] [Related]

  • 45. Factor IX thrombogenicity: in vivo effects on coagulation activation and a case report of disseminated intravascular coagulation.
    Small M, Lowe GD, Douglas JT, Forbes CD, Prentice CR.
    Thromb Haemost; 1982 Aug 24; 48(1):76-7. PubMed ID: 7135346
    [Abstract] [Full Text] [Related]

  • 46. Pharmacokinetic analysis of plasma-derived and recombinant F IX concentrates in previously treated patients with moderate or severe hemophilia B.
    Ewenstein BM, Joist JH, Shapiro AD, Hofstra TC, Leissinger CA, Seremetis SV, Broder M, Mueller-Velten G, Schwartz BA, Mononine Comparison Study Group.
    Transfusion; 2002 Feb 24; 42(2):190-7. PubMed ID: 11896334
    [Abstract] [Full Text] [Related]

  • 47. Safety and recovery of mononine in multiple-dose, high-dose regimens.
    White GC.
    Acta Haematol; 1995 Feb 24; 94 Suppl 1():53-7; discussion 57-8. PubMed ID: 7571996
    [Abstract] [Full Text] [Related]

  • 48. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
    Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM.
    J Lab Clin Med; 1993 Mar 24; 121(3):394-405. PubMed ID: 8445288
    [Abstract] [Full Text] [Related]

  • 49. Kinetics of factor IX activity differ from that of factor IX antigen in patients with haemophilia B receiving high-purity factor IX replacement.
    Liebman HA, Rosenwald-Zuckerman T, Retzios A, Yasmin S, Kasper CK.
    Haemophilia; 1999 May 24; 5(3):174-80. PubMed ID: 10444284
    [Abstract] [Full Text] [Related]

  • 50. Safety and efficacy of purified factor IX concentrate and antifibrinolytic agents for dental extractions in hemophilia B.
    Djulbegovic B, Marasa M, Pesto A, Kushner GM, Hadley T, Joseph G, Goldsmith G.
    Am J Hematol; 1996 Feb 24; 51(2):168-70. PubMed ID: 8579061
    [Abstract] [Full Text] [Related]

  • 51. Fusion of Factor IX to Factor XIII-B Sub-Unit Improves the Pharmacokinetic Profile of Factor IX.
    Le Quellec S, Enjolras N, Perot E, Girard J, Negrier C, Dargaud Y.
    Thromb Haemost; 2018 Dec 24; 118(12):2053-2063. PubMed ID: 30453348
    [Abstract] [Full Text] [Related]

  • 52. Preparation and properties of a therapeutic factor IX concentrate.
    Suomela H, Myllylä G, Raaska E.
    Vox Sang; 1977 Jul 24; 33(1):37-50. PubMed ID: 883244
    [Abstract] [Full Text] [Related]

  • 53. Standardization of factor IX: standards for "purified" factor IX concentrates.
    Lamb MA, Fricke WA, Rastogi SC.
    Thromb Haemost; 1991 Nov 01; 66(5):548-51. PubMed ID: 1803618
    [Abstract] [Full Text] [Related]

  • 54. Identification of prothrombin as a major thrombogenic agent in prothrombin complex concentrates.
    Dusel CH, Grundmann C, Eich S, Seitz R, König H.
    Blood Coagul Fibrinolysis; 2004 Jul 01; 15(5):405-11. PubMed ID: 15205589
    [Abstract] [Full Text] [Related]

  • 55. Assessment of potential thrombogenicity of coagulation factor IX concentrates in an in vitro model of human thrombogenesis.
    Galan AM, Reverter JC, Bozzo J, Hernandez MR, Escolar G, Aznar-Salatti J.
    Thromb Res; 1999 Dec 01; 96(5):383-9. PubMed ID: 10605953
    [Abstract] [Full Text] [Related]

  • 56. Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery.
    Schulman S, Wallensten R, White B, Smith OP.
    Haemophilia; 1999 Mar 01; 5(2):96-100. PubMed ID: 10215956
    [Abstract] [Full Text] [Related]

  • 57. Large-scale preparation and biochemical characterization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography.
    Feldman PA, Bradbury PI, Williams JD, Sims GE, McPhee JW, Pinnell MA, Harris L, Crombie GI, Evans DR.
    Blood Coagul Fibrinolysis; 1994 Dec 01; 5(6):939-48. PubMed ID: 7893930
    [Abstract] [Full Text] [Related]

  • 58. Human factor IX in animals: kinetics from isolated, radiolabelled protein and platelet destruction following crude concentrate infusions.
    Thompson AR, Forrey AW, Gentry PA, Smith KJ, Harker LA.
    Br J Haematol; 1980 Jun 01; 45(2):329-42. PubMed ID: 7437328
    [Abstract] [Full Text] [Related]

  • 59. Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro.
    Perzborn E, Heitmeier S, Laux V, Buchmüller A.
    Thromb Res; 2014 Apr 01; 133(4):671-81. PubMed ID: 24529498
    [Abstract] [Full Text] [Related]

  • 60. Disseminated intravascular coagulation in a patient with haemophilia B during factor IX replacement therapy.
    Ohga S, Saito M, Matsukazi A, Kai T, Ueda K.
    Br J Haematol; 1993 Jun 01; 84(2):343-5. PubMed ID: 8398841
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.